Simple Summary The microbiota can modulate immune responses and modify the
physiology of the human organism, thereby increasing infective risks and a neoplastic …

Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic
tools in cervical carcinoma screening and management of women with cervical …

Background: Several new assays have been developed for high-risk HPV testing of cervical
samples; we compare six HPV tests in a screening population. Methods: Residual material …

Background Atypical squamous cells of undetermined significance (ASCUS) and low‐grade
squamous intra‐epithelial lesions (LSIL) are minor lesions of the cervical epithelium …

BACKGROUND: The additional sensitivity of HPV testing compared with cytology could
permit extended cervical screening intervals. We wished to determine, through a further …

While organized screening programs in industrialized countries have significantly reduced
cervical cancer incidence, cytology-based screening has several limitations. Equivocal or …

The clearly higher sensitivity and reproducibility of human papillomavirus (HPV) DNA testing
for high-grade cervical intraepithelial neoplasia (CIN) has led to widespread calls to …

High-risk human papillomavirus (HPV) DNA/RNA testing provides higher sensitivity but
lower specificity than cytology for the identification of high-grade cervical intraepithelial …

The advent of US Food and Drug Administration (FDA)-approved molecular testing for
human papillomavirus (HPV) has resulted in a dramatic shift from cytological testing alone to …

Detection of human papillomavirus (HPV) E6/E7 oncogene expression may be more
predictive of cervical cancer risk than testing for HPV DNA. The Aptima HPV test (Gen …